BRITTANY WETHINGTON: Open Payments
NPI 1346710183 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 41 payments from 9 companies in 2025. Trend: 2023 $180 · 2024 $623 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $136 |
| Novo Nordisk Inc | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, UBRELVY, REXULTI, Wegovy, TAGRISSO, Auvelity, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
